8-K Announcements
6Material company update
May 15, 2026·SEC
Material company update
Apr 3, 2026·SEC
Material company update
Mar 27, 2026·SEC
Forian Inc.(FORA)Earnings, Financials & Key Ratios
FORA•NASDAQ
$2.17
Price updated Jun 20, 2026
AboutForian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.Show more
- Revenue$30M+50.1%
- EBITDA-$2M+67.6%
- Net Income-$3M+23.8%
- EPS (Diluted)-0.09+23.0%
- Gross Margin52.52%-17.4%
- EBITDA Margin-7.4%+78.4%
- Operating Margin-8.16%+76.5%
- Net Margin-9.5%+49.2%
- ROE-9.61%+26.4%
FORA Price & Volume
Forian Inc. (FORA) stock price & volume — 10-year historical chart
Loading chart...
Operational Volatility Challenges Forian's Scalability Prospects
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Healthy
Cash Flow:Burning
Primary Risk:High Revenue Volatility
Key Thesis Takeaways
- Forian faces a precarious transition as revenue growth has shifted from a 65.6% peak in 2025Q3 to a 2.9% contraction by 2026Q1, signaling significant instability in its core market segments.
- While the company has successfully deleveraged its balance sheet to near-zero debt, the persistent inability to achieve positive operating income—evidenced by a $2.9M deficit in 2026Q1—suggests that the current business model lacks the necessary scale to cover overhead.
- Investors should remain cautious as stock-based compensation of $548.6K continues to obscure the underlying cash burn and operational inefficiencies.
Verdict Logic
the company's inability to maintain consistent profitability, highlighted by a -49.1% net margin in 2026Q1, suggests that the current operational structure remains fundamentally unsustainable for long-term equity value creation.
FORA Growth Metrics
Forian Inc. (FORA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years123.31%
3 Years22.6%
TTM34.57%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-38.7%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-40.25%
Return on Capital
10 Years-43.46%
5 Years-34.01%
3 Years-12.29%
Last Year-8.18%
FORA Recent Earnings
Forian Inc. (FORA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (55%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
May 15, 2026Metric
Actual
Est
EPS
$0.09-550.0%
$0.02
Rev
$7M-10.1%
$8M
Q2 2026
Mar 27, 2026Metric
Actual
Est
EPS
$0.04-500.0%
$0.01
Rev
$8M+3.4%
$8M
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$0.02+100.0%
$0.01
Rev
$8M+0.8%
$8M
Q3 2025
Aug 13, 2025Metric
Actual
Est
EPS
$0.03+200.0%
$0.01
Rev
$7M+2.9%
$7M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.09vs $0.02-550.0% | $7Mvs $8M-10.1% |
| Q2 2026 | Mar 27, 2026 | $0.04vs $0.01-500.0% | $8Mvs $8M+3.4% |
| Q4 2025 | Nov 14, 2025 | $0.02vs $0.01+100.0% | $8Mvs $8M+0.8% |
| Q3 2025 | Aug 13, 2025 | $0.03vs $0.01+200.0% | $7Mvs $7M+2.9% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Forian Inc. (FORA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.17 | $67.79M | -23.48 | 50.13% | -9.5% | -9.61% | — | |
| $9.69 | $195.56M | 31.26 | 6.36% | 5.56% | 14% | — | |
| $2.27 | $167.74M | -0.89 | 1.48% | -87.69% | -99.78% | — | |
| $29.87 | $12.66B | 1799.40 | 18.67% | 0.74% | 0.3% | — | |
| $20.51 | $1.24B | 19.72 | -0.13% | 6.87% | 4.6% | — | |
| $72.14 | $4.3B | 33.87 | 11.66% | 9.03% | 8.95% | — |
Compare FORA vs Peers
Forian Inc. (FORA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
FORA SEC Filings & Documents
Forian Inc. (FORA) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when FORA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
FORA Frequently Asked Questions
Forian Inc. (FORA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Forian Inc.'s revenue?
Forian Inc. (FORA) reported $30.1M in revenue for fiscal year 2025.
How fast is Forian Inc. growing?
Forian Inc. (FORA) grew revenue by 50.1% over the past year. This is strong growth.
Is FORA profitable?
Forian Inc. (FORA) reported a net loss of $5.1M for fiscal year 2025.
Dividend & Returns
What is FORA's return on equity?
Forian Inc. (FORA) has a return on equity (ROE) of -9.6%. Negative ROE indicates the company is unprofitable.
What is Forian Inc.'s free cash flow?
Forian Inc. (FORA) generated $2.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.